BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2015
View Archived Issues
Preclinical results presented for a BAX activator molecule
Read More
Sunitinib shows antitumor activity in thyroid cancer patients
Read More
Prozymex reports development of DPP-I inhibitors
Read More
University of Texas System patent describes new engineered primate L-methioninase
Read More
Peloton Therapeutics presents HIF-2alpha inhibitors
Read More
Dako and Amgen expand companion diagnostics collaboration
Read More
Scientists design novel PHEO mouse model
Read More
Imaging agent 64Cu-DOTA-AE-105 tested in prostate cancer patients
Read More
Further clinical data reported for preregistered hypercholesterolemia treatment evolocumab
Read More
La Jolla initiates phase III trial of LJPC-501 for catecholamine-resistant hypotension
Read More
ThromboGenics reports topline data on Jetrea in symptomatic vitreomacular adhesion
Read More
Nippon Shinyaku to continue clinical development of NS-065 for DMD
Read More
GenVec and TheraBiologics to develop cancer therapies based on neural stem cell technology
Read More
New S1P1 antagonist presented for the treatment of autoimmune disease
Read More
Gilead's sofosbuvir approved in Japan for genotype 2 HCV infection
Read More
Regulus receives European orphan medicinal product designation for RG-012
Read More
FDA approves Regeneron's aflibercept for diabetic retinopathy in diabetic macular edema
Read More
Quadracel approved in U.S. for vaccination of children aged 4-6 years
Read More
EUSA Pharma regains independence from Jazz Pharmaceuticals
Read More
Università degli Studi di Padova describes use of SERPINB3 for SLE
Read More
Therapure Innovations receives FDA approval to conduct phase I trial of TBI-302
Read More
Calitor Sciences discloses ALK and/or HGFR inhibitors
Read More
Sun Pharmaceutical completes acquisition of Ranbaxy from Daiichi Sankyo
Read More
FDA approves Emergent BioSolutions' Anthrasil for treatment of inhalational anthrax
Read More
MBX-8025 gains U.S. orphan drug status for homozygous familial hypercholesterolemia
Read More
Lilly's Cyramza obtains approval for gastric cancer in Japan
Read More
